Assure Holdings Investor Presentation — December 2022

Document content

Investor Presentation

December 2022 | NASDAQ: IONM

Cautionary Note regarding Forward -Looking Statements

This presentation may contain “forward -looking statements” within the meaning of applicable securities laws. Forward -looking sta tements may generally be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "wo uld," "may,"

"will," "believes," "estimates," "potential," "target," or "continue" and variations or similar expressions. Forward -looking sta tements include, but are not limited to, statements regarding forecasts of managed cases and remote neurology managed cases, the effect of cost

reductions and projected savings, financial projections, including the company being Adjusted EBITDA and cash flow positive i n the second half of 2022, and other similar statements. These statements are based upon the current expectations and beliefs of management

and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward -looking statements. These risks include risks regarding our patient volume or cases not growing as expected, or decr easing, which could

impact revenue and profitability; unfavorable economic conditions could have an adverse effect on our business; risks related toincreased leverage resulting from incurring additional debt; the policies of health insurance carriers may affect the amount ofrevenue we

receive; our ability to successfully market and sell our products and services; we may be subject to competition and technolo gical risk which may impact the price and amount of services we can sell and the nature of services we can provide; regulatory c han ges that are

unfavorable in the states where our operations are conducted or concentrated; our ability to comply and the cost of complianc e with extensive existing regulation and any changes or amendments thereto; changes within the medical industry and third -party rei mbursement

policies and our estimates of associated timing and costs with the same; our ability to adequately forecast expansion and the Company’s management of anticipated growth; and risks and uncertainties discussed in our most recent annual and quarterly repor ts filed with the

United States Securities and Exchange Commission, including our annual report on Form 10 -K filed on March 14, 2022, and with the Canadian securities regulators and available on the Company’s profiles on EDGAR at www.sec.gov and SEDAR at www.sedar.com , which

risks and uncertainties are incorporated herein by reference. Readers are cautioned not to place undue reliance on forward -looki ng statements. Except as required by law, Assure does not intend, and undertakes no obligation, to update any forward -looking st atements to